|
|
|
|
Direct Cost |
Indirect Cost |
|
| 5UC7AI180306-02 |
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory |
UNIVERSITY OF MISSOURI-COLUMBIA |
NIAID |
$1,517,706 |
$857,504 |
$2,375,210 |
| 5U42OD011140-22 |
National Swine Resource and Research Center (NSRRC) Years 21-25 |
UNIVERSITY OF MISSOURI-COLUMBIA |
OD |
$960,898 |
$542,907 |
$1,503,805 |
| 5U42OD010918-25 |
The Mutant Mouse Resource and Research Center at the University of Missouri |
UNIVERSITY OF MISSOURI-COLUMBIA |
OD |
$943,222 |
$547,941 |
$1,491,163 |
| 5U42OD035738-02 |
Swine Somatic Cell Gene Editing Testing Center |
UNIVERSITY OF MISSOURI-COLUMBIA |
OD |
$849,598 |
$480,023 |
$1,329,621 |
| 5P40OD011062-24 |
Rat Resource and Research Center |
UNIVERSITY OF MISSOURI-COLUMBIA |
OD |
$936,007 |
$364,185 |
$1,300,192 |
| 5R56AG079586-02 |
Gut-brain axis in Alzheimer's disease: translational 7T MRI markers and underlying mechanisms |
UNIVERSITY OF MISSOURI-COLUMBIA |
NIA |
$666,427 |
$131,382 |
$797,809 |
| 5R01AI169781-02 |
A prophylactic vaccine to prevent colonization by Pseudomonas aeruginosa |
UNIVERSITY OF MISSOURI-COLUMBIA |
NIAID |
$602,999 |
$169,499 |
$772,498 |
| 5R01OD035561-02 |
Enhancing The Value of Pigs for Agriculture and Biomedical Applications By Using Novel Genome Editing Strategies |
UNIVERSITY OF MISSOURI-COLUMBIA |
OD |
$489,928 |
$276,809 |
$766,737 |
| 5R35GM122564-07 |
Adeno-Associated Virus Gene Therapy Vectors: Molecular Interactions on Cell Entry |
UNIVERSITY OF MISSOURI-COLUMBIA |
NIGMS |
$511,276 |
$254,185 |
$765,461 |
| 1UG3CA290305-01 |
Developing a novel agonist of CD137 for cancer immunoprevention |
UNIVERSITY OF MISSOURI-COLUMBIA |
NCI |
$494,900 |
$266,194 |
$761,094 |
| 1R01HL169266-01A1 |
p16 Cellular Senescence and Vascular Dysfunction in Sleep Apnea |
UNIVERSITY OF MISSOURI-COLUMBIA |
NHLBI |
$493,730 |
$251,391 |
$745,121 |
| 5R01AI152521-04 |
Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines |
UNIVERSITY OF MISSOURI-COLUMBIA |
NIAID |
$503,637 |
$218,424 |
$722,061 |
| 5R01HL151444-03 |
Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosis |
UNIVERSITY OF MISSOURI-COLUMBIA |
NHLBI |
$473,720 |
$248,301 |
$722,021 |
| 5R01DE022971-14 |
THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION |
UNIVERSITY OF MISSOURI-COLUMBIA |
NIDCR |
$539,269 |
$181,149 |
$720,418 |
| 5U01EY031650-05 |
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard |
UNIVERSITY OF MISSOURI-COLUMBIA |
NEI |
$467,116 |
$251,740 |
$718,856 |
| 5R24OD030214-03 |
A genomic toolkit for functional interrogation of trait variation in an aquatic model |
UNIVERSITY OF MISSOURI-COLUMBIA |
OD |
$573,724 |
$144,803 |
$718,527 |
| 5R01HD108198-04 |
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive |
UNIVERSITY OF MISSOURI-COLUMBIA |
NICHD |
$612,659 |
$78,902 |
$691,561 |
| 5R01HL166183-02 |
GABA signaling in the nTS and cardiorespiratory responses to hypoxia |
UNIVERSITY OF MISSOURI-COLUMBIA |
NHLBI |
$432,539 |
$244,385 |
$676,924 |
| 5R01HL151384-04 |
Targeting ADAM17 activity for correction of vascular insulin resistance in type 2 diabetes |
UNIVERSITY OF MISSOURI-COLUMBIA |
NHLBI |
$432,982 |
$234,933 |
$667,915 |
| 5R01AI158477-03 |
Genetically modified pigs to model NKT cell immunity to influenza virus infection |
UNIVERSITY OF MISSOURI-COLUMBIA |
NIAID |
$479,170 |
$180,420 |
$659,590 |